AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| BLT | Nasdaq today | 24/04/18 | 15 | 2.6K | |||
|
|||||||
| BLT | Ann: CORPORATE PRESENTATION | 24/04/18 | 0 | 100 | |||
|
|||||||
| BLT | Ann: CLINICAL PROGRAM UPDATE | 24/04/18 | 0 | 134 | |||
|
|||||||
| BLT | DIRK Blog | 24/04/18 | 0 | 150 | |||
|
|||||||
| BLT | A Future Without Death-Celularity CEO | 24/04/18 | 0 | 131 | |||
|
|||||||
| BLT | Gene Therapy | 20/04/18 | 5 | 1.5K | |||
|
|||||||
| BLT | Falling behind again? | 19/04/18 | 1 | 366 | |||
|
|||||||
| BLT | Cancer | 16/04/18 | 25 | 6.5K | |||
|
|||||||
See All Discussions
ASX News